{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-009711","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.998730+00:00","generated_at":"2026-06-25T04:38:13.043225+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GlycoMimetics receives Nasdaq minimum bid price deficiency notice","bullets":["Bid price below $1.00 for 30 consecutive business days; 180-day cure period until Nov 28, 2022.","Compliance requires closing bid price at or above $1.00 for at least 10 consecutive business days.","If not cured, Company may transfer to Nasdaq Capital Market for additional 180-day period if eligible.","Noncompliance has no immediate effect on listing or trading of common stock on The Nasdaq Global Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-009711","json":"https://secwatch.observer/filing/0001558370-22-009711.json","markdown":"https://secwatch.observer/filing/0001558370-22-009711.md","text":"https://secwatch.observer/filing/0001558370-22-009711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000155837022009711/0001558370-22-009711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000155837022009711/glyc-20220531x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:38:13.043225+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}